Modern Medicine Basis of Dredging and Supplementing Collaterals Method Reversing the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Deficiency and Collateral Stasis Syndrome

LIU Yantong; LYU Xiaodong; PANG Lijian; LIU Chuang; LIU Yongming

doi:10.13288/j.11-2166/r.2017.16.009

您当前的位置：

首页 >

文章列表页 >

Modern Medicine Basis of Dredging and Supplementing Collaterals Method Reversing the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Deficiency and Collateral Stasis Syndrome

更新时间：2021-11-10

- Modern Medicine Basis of Dredging and Supplementing Collaterals Method Reversing the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Deficiency and Collateral Stasis Syndrome
- Journal of Traditional Chinese Medicine Vol. 58, Issue 16, Pages: 1381-1384(2017)
- 作者机构：
  
  1. 辽宁中医药大学第一临床学院
  2. 辽宁中医药大学附属医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2017.16.009
  CLC： R259
- Published：2017
- 稿件说明：
移动端阅览
[1]刘妍彤,吕晓东,庞立健,刘创,刘勇明.通络补络法扭转特发性肺纤维化肺虚络瘀病机的现代医学基础[J].中医杂志,2017,58(16):1381-1384.

LIU Yantong, LYU Xiaodong, PANG Lijian, et al. Modern Medicine Basis of Dredging and Supplementing Collaterals Method Reversing the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Deficiency and Collateral Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2017, 58(16): 1381-1384.
[1]刘妍彤,吕晓东,庞立健,刘创,刘勇明.通络补络法扭转特发性肺纤维化肺虚络瘀病机的现代医学基础[J].中医杂志,2017,58(16):1381-1384. DOI： 10.13288/j.11-2166/r.2017.16.009.

LIU Yantong, LYU Xiaodong, PANG Lijian, et al. Modern Medicine Basis of Dredging and Supplementing Collaterals Method Reversing the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Deficiency and Collateral Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2017, 58(16): 1381-1384. DOI： 10.13288/j.11-2166/r.2017.16.009.

摘要

特发性肺纤维化的核心病机为肺虚络瘀

将通络补络法作为治疗特发性肺纤维化的基本治法

具有一定疗效

其现代医学基础是通过调节转化生长因子β

（TGF-β

）介导的传导通路的失衡、抗肺泡上皮细胞过度凋亡、抗氧化应激损伤三个方面

从而延缓特发性肺纤维化的进程。

Abstract

The core pathogenesis of idiopathic pulmonary fibrosis（ IPF） is lung deficiency and collateral stasis.It is effective to take dredging and supplementing collaterals method as the basic therapy in treating IPF. The modern medicine basis is delaying the course of IPF by 3 aspects: regulating the imbalance of conduction pathway mediated by transforming growth factorβ

（ TGF-β

）

anti-excessive apoptosis of alveolar epithelial cells and anti-oxidative stress injury.

关键词

Keywords

references

查看原文

Views

272

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of Idiopathic Pulmonary Fibrosis Using the Method of Unblocking Collaterals with Acrid and Moistened Medicinals Based on Xuanfuhua Decoction （旋覆花汤）

Effect of Yiqi Yangyin Huoxue Tongluo Formula（益气养阴活血通络方）on Platelet Activation and Lung Tissue CD40-CD40L System in Idiopathic Pulmonary Fibrosis Model Rats

Jianpi Tongluo Formula （健脾通络方） in the Treatment of 58 Cases of Idiopathic Pulmonary Fibrosis with Spleen Deficiency and Collateral Stasis Pattern： A Randomized Controlled Trial

PANG Qinglu1，LI Guodong2，CAO Fang3，LIU Haoge1，WEI Wan3，JIAO Yang3

Effect of Wenfei Huaxian Decoction （温肺化纤汤） on Aerobic Glycolysis of Hydrogen Peroxide-induced Oxidative Stress Injury of Lung Mesenchymal Stem Cells in Mice

Related Author

MIAO Qing

YANG Zi

CAO Sheng

RUAN Zhishen

KONG Jinli

FAN Yiling

LI Rui

LIU Yongming

Related Institution

Graduate School，Beijing University of Chinese Medicine

Xiyuan Hospital，China Academy of Chinese Medical Sciences

Liaoning University of Traditional Chinese Medicine Hospital Subsidiary Fourth

Liaoning University of Traditional Chinese Medicine

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰